Accenture Plc is a management consulting, technology services and outsourcing organization. The Company's business is structured around five operating groups, namely, Communications & High Tech, Financial Services, Products, Public Service and Resources. Combining unparalleled experience, comprehensive capabilities across all industries and business functions, and extensive research on the world's most successful companies, Accenture collaborates with clients to help them become high-performance businesses and governments. Accenture Plc is headquartered in New York.
Companies in this category produce a huge variety of different products. Most are related to the medical field, but as diverse as that field is, so are the products these firms produce. While some products are used solely for the aesthetic and therapeutic care of the patient, others are used for more urgent or life-saving practices. Several companies on this list are developing more accurate and efficient MRI scanners and one is even hoping to offer an alternative to the uncomfortable traditional mammography women typically have to endure. On the life-saving side of this group, many companies have products that help those with potentially lethal arrhythmias to control them and lead a normal life. Several others have products either on the market or in the works that will help those with other problems such as bladder control, neurological damage, and prostate disorders.
|
| Totals |
Company |
Industry |
| Sales: |
$41,603.4 Mil |
$88,952.3 Mil |
| Market Cap: |
$104,005.2 Mil |
$352,863.7 Mil |
| Analysts Recommendation: |
Strong Buy |
Buy |
|
|
| Averages |
Company |
Industry |
 |
| Growth |
| Historic Revenue: |
13.2% |
18.2% |
| Estimated Revenue: |
2.7% |
4.1% |
| Historic Earnings: |
14.0% |
14.5% |
| Estimated Earnings: |
8.2% |
16.0% |
| Stock Price (1 Year): |
(2.0%) |
(13.3%) |
| Cash per Share: |
22.0% |
25.1% |
| Dividend: |
N/A |
N/A |
| Price |
| Trailing PE: |
N/A |
N/A |
| Forward PE: |
20.3 |
24.8 |
| Price-to-Sales: |
2.5 |
N/A |
| Price-to-Book: |
9.5 |
3.7 |
| Dividend Yield: |
N/A |
N/A |
| Market Cap: |
$104,005.2 Mil |
$12,167.7 Mil |
| Operations |
| Net Margin: |
10.6% |
14.0% |
| Gross Margin: |
29.9% |
54.0% |
| Return on Equity: |
.4 |
.1 |
| Return on Assets: |
.2 |
.1 |
| Balance Sheet |
| Current Ratio: |
1.3 |
3.0 |
| Quick Ratio: |
1.3 |
2.4 |
| Cash Ratio: |
.5 |
1.2 |
| Debt-to-Equity: |
1.3 |
.8 |
| Interest Coverage: |
(.7) |
.1 |
| Technicals |
| Relative-Strength Index: |
77.5 |
N/A |
|
|
|
